CDC investigates fungal endophthalmitis cases

The Centers for Disease Control and Prevention (CDC) will investigate cases of fungal endophthalmitis that appear to be unrelated to those associated with a Florida company that led to last month's FDA recall of Brilliant Blue G (see Ophthalmology Times eReport, March 28, 2012).

Full Story →